Findings of a clinic monitoring report released last week, again highlighted how delivery of health services in the Eastern Cape are hamstrung by staff and medicine shortages. Luvuyo Mehlwana unpacks the data and the provincial health department’s plans to address the challenges identified in the report.
Many clinics in Limpopo are operating without the required number of staff needed to deliver quality healthcare services, according to a report from Ritshidze, a community healthcare monitoring project. Activists say these staff shortages contribute to long waiting times for patients and overworked staff – which can ultimately undermine the province’s HIV programme.
Stockouts of essential medicines have been a problem in North West province for years. Now, a new community monitoring report suggests many people are still being turned away from public sector clinics without treatment or asked to come back a week later. Thabo Molelekwa spoke to the people behind the report and asked the North West Department of Health for their response to it.
The ongoing stockouts of contraceptives grossly violate individuals’ and couples’ reproductive rights but alternative measures have not been put in place. If the issues of access to contraceptives are not dealt with, the country will face a baby boom and a rise in HIV infections at the end of the current pandemic writes Thuthukile Mbatha and Annah Maluleke.
Community Health Workers (CHWs) are an important element in the government’s re-engineering of primary health care strategy. Here Melanie Alperstein and Tinashe Njanji highlight the challenges CHWs in the Eastern Cape face and offer some solutions to improve the working conditions of CHWs and improve health outcomes in the province.
In recent months, the world has seen unprecedented investment in new vaccines. Yet, while a COVID-19 vaccine proven to be safe and effective may be less than a year away, a new tuberculosis vaccine might only be ready to be rolled out in a decade, despite a massive head start over COVID-19. Amy Green takes a closer look at the race for a new vaccine for the world’s top infectious disease killer.